ArticleThe Lancet. Infectious diseases2023

Real-world effectiveness of nirmatrelvir-ritonavir against BA.4 and BA.5 omicron SARS-CoV-2 variants.

Carlos K H Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.